Literature DB >> 18333201

Preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma.

Jacques Belghiti1, Satoshi Ogata.   

Abstract

Optimal preoperative preparation is required to reduce operative risk of major hepatectomy in jaundiced patients. The role of percutaneous preoperative biliary drainage (PTBD) is, apart from assessment of intraductal extent of the tumour, to allow contralateral hypertrophy if portal vein embolization (PVE) is performed. The increased use of PTBD over a 10-year period was associated with increased resectability rate in this study, while PTBD-related complications decreased. Efficient hypertrophy of the future liver remnant (FLR) requires biliary drainage to reduce the risk of postoperative liver dysfunction. Preoperative staging laparoscopy avoided unnecessary surgical exploration in 20% of patients previously considered resectable.

Entities:  

Year:  2005        PMID: 18333201      PMCID: PMC2043095          DOI: 10.1080/13651820500372335

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  9 in total

Review 1.  Biliary tract cancers.

Authors:  P C de Groen; G J Gores; N F LaRusso; L L Gunderson; D M Nagorney
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

2.  Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients.

Authors:  Sharon M Weber; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

3.  Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial.

Authors:  A R Hatfield; R Tobias; J Terblanche; A H Girdwood; S Fataar; R Harries-Jones; L Kernoff; I N Marks
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

4.  Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion.

Authors:  A A Polydorou; S R Cairns; J F Dowsett; A R Hatfield; P R Salmon; P B Cotton; R C Russell
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

5.  Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage.

Authors:  D Cherqui; S Benoist; B Malassagne; R Humeres; V Rodriguez; P L Fagniez
Journal:  Arch Surg       Date:  2000-03

6.  Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate.

Authors:  Yasuji Seyama; Keiichi Kubota; Keiji Sano; Tamaki Noie; Tadatoshi Takayama; Tomoo Kosuge; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

7.  Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial.

Authors:  G A McPherson; I S Benjamin; H J Hodgson; N B Bowley; D J Allison; L H Blumgart
Journal:  Br J Surg       Date:  1984-05       Impact factor: 6.939

8.  Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.

Authors:  Tomoki Ebata; Masato Nagino; Junichi Kamiya; Katsuhiko Uesaka; Tetsuro Nagasaka; Yuji Nimura
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

9.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

  9 in total
  17 in total

Review 1.  Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review.

Authors:  Fei Liu; Ya Li; Yonggang Wei; Bo Li
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

Review 2.  Current status of preoperative biliary drainage.

Authors:  Junko Umeda; Takao Itoi
Journal:  J Gastroenterol       Date:  2015-07-03       Impact factor: 7.527

3.  [Surgical therapy of hilar cholangiocarcinoma].

Authors:  H Lang; G M Kaiser; T Zöpf; G C Sotiropoulos; A Frilling; M Malagó; C E Broelsch
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

4.  Radical surgery in the presence of biliary metallic stents: revising the palliative scenario.

Authors:  Dimitrios Lytras; Steven W M Olde Damink; Zahir Amin; Charles J Imber; Massimo Malagó
Journal:  J Gastrointest Surg       Date:  2011-01-19       Impact factor: 3.452

Review 5.  Preoperative biliary drainage in malignant obstruction: indications, techniques, and the debate over risk.

Authors:  Alan Coss; Michael F Byrne
Journal:  Curr Gastroenterol Rep       Date:  2009-04

Review 6.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

Review 7.  Preoperative biliary drainage in patients with obstructive jaundice: history and current status.

Authors:  N A van der Gaag; J J Kloek; S M M de Castro; O R C Busch; T M van Gulik; D J Gouma
Journal:  J Gastrointest Surg       Date:  2008-08-23       Impact factor: 3.452

8.  Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma.

Authors:  Dario Ribero; Giuseppe Zimmitti; Thomas A Aloia; Junichi Shindoh; Forchino Fabio; Marco Amisano; Guillaume Passot; Alessandro Ferrero; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2016-02-13       Impact factor: 6.113

Review 9.  Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

Authors:  Kevin C Soares; Ihab Kamel; David P Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

10.  Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy.

Authors:  Jun-Jie Xiong; Quentin M Nunes; Wei Huang; Samir Pathak; Ai-Lin Wei; Chun-Lu Tan; Xu-Bao Liu
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.